<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en">
<head>
<title>Ewelina Weglarz-Tomczak</title>
<meta http-equiv="Content-Type" content="text/html;charset=UTF-8" />
<link rel="stylesheet" type="text/css" media="screen" href="css/main.css" />
<script src="http://ajax.googleapis.com/ajax/libs/jquery/1.3.2/jquery.min.js" type="text/javascript"></script>
<script src="js/functions.js" type="text/javascript"></script>
</head>
<body>
<div id="header">
  <ul>
    <li><a href="index.html"><span>Home</span></a></li>
	<li><a href="teaching.html"><span>Teaching</span></a></li>
	<li><a href="cv.html"><span>CV</span></a></li>
  </ul>
</div>

<!--       ABOUT       --->
<div id="about">
  <div id="story" align="justify">
    <h1>Ewelina Węglarz-Tomczak</h1>
	<p> I am a biochemist, systems biologist and drug designer/medicinal chemist. I received PhD with Honours from <a href="http://bioorganic.ch.pwr.wroc.pl/index.php/Main_Page">Department of Bioorganic Chemistry</a> at <a href="http://pwr.edu.pl/en/"> Wroclaw University of Science and Technology</a>. I worked at Synthetic Systems Biology Group in <a href="http://sils.uva.nl/">Swammerdam Institute for Life Sciences</a> at the <a href="http://www.uva.nl/en/home">University of Amsterdam</a> before joining the Molecular Biology and Microbial Food Safety, where I am a parttime 
Senior Postdoc/Principal Investigator.</p>
	<p><img border="0" alt="mail" src="images/mail_green.png" width="15" height="15">&nbsp; ewelina.weglarz.tomczak<img border="0" alt="@" src="images/at.png" width="15" height="15">gmail.com</p>
  </div>
  <ul id="contact">
  <li><large-text>Find out more at:</large-text></li>
  <li><a href="https://scholar.google.com/citations?user=lNofuWcAAAAJ&hl=pl&oi=ao" target="_blank"><img border="0" alt="scholar" src="images/scholar.png" width="40" height="40"></a>&nbsp; 
<a href="http://www.uva.nl/en/profile/w/e/e.m.weglarz-tomczak/e.m.weglarz-tomczak.html" target="_blank"><img border="0" alt="scholar" src="images/uva.png" width="40" height="40"></a>&nbsp; 
<a href="https://orcid.org/0000-0001-8080-2801" target="_blank"><img border="0" alt="scholar" src="images/orcid.png" width="40" height="40"></a>&nbsp;
<a href="https://nl.linkedin.com/in/ewelina-weglarz-tomczak-04b8821ab" target="_blank"><img border="0" alt="scholar" src="images/linkedin.png" width="40" height="40"></a>
<a href="https://twitter.com/TomczakWeglarz" target="_blank"><img border="0" alt="scholar" src="images/twitter.png" width="40" height="40"></a>

</li>
  </ul>
  <img id="picture" src="images/20210329_231905.jpg" alt="" /> </div>

<!--       ABOUT ME       --->
<div class="section">
  <h2>My research</h2>

   <div class="item">
    <div class="description">
	    <p>My research is mainly focused on developing new methods for integrating <b>gene expression/proteomics data</b> with <b>environmental factors</b> such as <b>nutrient availability</b> (and/or <b>microbiota</b>) and <b>studying cell metabolism</b>. I use a <b>genome-scale metabolic map</b> as a modeling platform and <b>cell lines as experimental models</b>. Moreover, I work on <b>developing computational methods for reverse engineering in biological systems</b>, namely, <b>parameter identification of dynamic models</b>. Recently, in response to the pandemic of COVID-19, I lead a project on the development of the potential treatment using ebselen and its derivatives.</p>
    </div>
   </div>
	
</div>

<!--       NEWS       --->
<div class="section">
  <h2>News</h2>
	
   <div class="item">
    <div class="date">2021/03/19</div>
    <div class="description">
	    <p>Our paper "Simultaneous Integration of Gene Expression and Nutrient Availability for Studying the Metabolism of Hepatocellular Carcinoma Cell Lines" got accepted to Biomolecules <a href="https://doi.org/10.3390/biom11040490" target="_blank">[View at Publisher]</a> </p>
    </div>
   </div>	
	
   <div class="item">
    <div class="date">2021/02/01</div>
    <div class="description">
	    <p>Our paper "GEM-based metabolic profiling for Human Bone Osteosarcoma under different glucose and glutamine availability" got accepted to IJMS <a href="https://doi.org/10.3390/ijms22031470" target="_blank">[View at Publisher]</a> </p>
    </div>
   </div>
	
   <div class="item">
    <div class="date">2021/01/25</div>
    <div class="description">
	    <p>Our paper "M2R: a Python add-on to cobrapy for modifying human genome-scale metabolic reconstruction using the gut microbiota models" got accepted to Bioinformatics <a href="https://doi.org/10.1093/bioinformatics/btab060" target="_blank">[View at Publisher]</a> </p>
    </div>
   </div>	

   <div class="item">
    <div class="date">2021/01/08</div>
    <div class="description">
	    <p>Our paper "Identification of ebselen and its analogues as potent covalent inhibitors of SARS-CoV-2 PLpro" got accepted to Nature Scientific Report.</p>
    </div>
   </div>
	
   <div class="item">
    <div class="date">2020/12/30</div>
    <div class="description">
	    <p>Our paper "Population-Based Parameter Identification for Dynamical Models of Biological Networks with an Application to Saccharomyces cerevisiae" got accepted to Processes <a href="https://doi.org/10.3390/pr9010098" target="_blank">[View at Publisher]</a> </p>
    </div>
   </div>
	
   <div class="item">
    <div class="date">2020/12/25</div>
    <div class="description">
	    <p>P2R grant from Innovation Exchange Amsterdam (@IXA_Amsterdam) for my research on COVID-19 <a href="https://www.ixa.nl/news/new-physics2market-projects-funded/" target="_blank">[IXA]</a> </p>
    </div>
   </div>

   <div class="item">
    <div class="date">2020/12/24</div>
    <div class="description">
      <p> New version of GENSI paper "Simultaneous integration of gene expression and nutrient availability for studying metabolism of hepatocellular carcinoma" is available online <a href="https://doi.org/10.1101/674150 " target="_blank">[Biorxiv]</a> </p>
    </div>
   </div>

   <div class="item">
    <div class="date">2020/09/19</div>
    <div class="description">
      <p> Our paper "Population-based Optimization for Kinetic Parameter Identification in Glycolytic Pathway in Saccharomyces cerevisiae" is available online <a href="arXiv:2010.06456" target="_blank">[Arxiv]</a> </p>
    </div>
   </div>

   <div class="item">
    <div class="date">2020/09/09</div>
    <div class="description">
      <p> Our paper "GEM-based metabolic profiling for Human Bone Osteosarcoma under different glucose and glutamine availability" is available online <a href="https://doi.org/10.1101/2020.09.08.287342" target="_blank">[Biorxiv]</a> </p>
    </div>
   </div>
	
   <div class="item">
    <div class="date">2020/03/20</div>
    <div class="description">
	    <p>Our paper got accepted to GECCO 2020: <a href="https://arxiv.org/abs/2002.02869" target="_blank">[here]</a></p>
    </div>
   </div>
	
   <div class="item">
    <div class="date">2019/06/27</div>
    <div class="description">
      <p>Our paper "Estimating kinetic constants in the Michaelis–Menten model from one enzymatic assay using ApproximateBayesian Computation" got accepted to FEBS Letters.</p>
    </div>
   </div>
	
   <div class="item">
    <div class="date">2019/06/18</div>
    <div class="description">
      <p>Our paper "Nature and Nurture integrated through an adjustable Flux Balance Analysis: The impact of cell-nutrition changes on the Warburg effect in hepatocellular carcinoma" is available online.</p>
    </div>
   </div
	
</div>

<!--    PUBLICATIONS    --->
<div id="publications" class="section">
  <h2>Publications</h2><br><br>
  <div class="item">
    <!--    journal articles    --->
    <h3>Journal articles</h3>
    <div class="description" align="justify">
      <p><ol>
	<li> <b>Węglarz-Tomczak, E.</b>, Tomczak, J. M., Talma, M., Burda-Grabowska, M., Giurg, M., Brul, S."Identification of ebselen and its analogues as potent covalent inhibitors of SARS-CoV-2 PLpro " Accepted in Nature Scientific Report.</a></li>
	<li> <b>Węglarz-Tomczak, E.</b>, Rijlaarsdam D.J., Tomczak, J. M., Brul, S. "GEM-based metabolic profiling for Human Bone Osteosarcoma under different glucose and glutamine availability" bioRxiv 2020, <a href="https://doi.org/10.1101/2020.09.08.287342 " target="_blank">[BioRxiv]</a></li>
	<li> <b>Węglarz-Tomczak, E.</b>, Tomczak, J. M., Brul, S. "M2R: a Python add-on to cobrapy for modifying human genome-scale metabolic reconstruction using the gut microbiota models" Accepted to Bioinformatics.</a></li>
	<li> <b>Węglarz-Tomczak, E.</b>, Tomczak, J. M., Eiben A.E., Brul, S. "Population-based Optimization for Kinetic Parameter Identification in Glycolytic Pathway in Saccharomyces cerevisiae" Processes 2021, 9 (1), 98. <a href="https://doi.org/10.3390/pr9010098" target="_blank">[View at Publisher]</a></li>
	<li> <b>Węglarz-Tomczak, E.</b>, Tomczak, J. M., Burda-Grabowska, M., Giurg, M., Brul, S."Discovery of potent inhibitors of PLproCoV2 by screening libraries of selenium-containing compounds " bioRxiv 2020 <a href="https://doi.org/10.1101/2020.05.20.107052" target="_blank">[BioRxiv]</a></li>
	<li> <b>Węglarz-Tomczak, E.</b>, Tomczak, J. M., BTalma, M., Giurg, M., Brul, S."Ebselen as a highly active inhibitor of PLProCoV2" bioRxiv 2020 <a href="https://doi.org/10.1101/2020.05.17.100768" target="_blank">[BioRxiv]</a></li>
	<li> <b>Węglarz-Tomczak, E.</b>, Mondeel, T.D.G.A., Piebes, D.G.E., Westerhoff, H.V., "Simultaneous integration of gene expression and nutrient availability for studying metabolism of hepatocellular carcinoma" bioRxiv 2020, <a href="https://doi.org/10.1101/674150 "_blank">[BioRxiv]</a></li>
	<li> Tomczak, J.M., <b>Węglarz-Tomczak, E.</b>, "Estimating kinetic constants in the Michaelis-Menten model from one measurement using Approximate Bayesian Computation" FEBS Letters (2019), <a href="https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1873-3468.13531" target="_blank">[Wiley]</a></li>
	<li> Drewniak, M., <b>Węglarz-Tomczak, E.</b>, Ożga, K., Rudzińska-Szostak, E., Macegoniuk, K., Tomczak, J.M., Bejger, M., Rypniewski, W., and Berlicki, Ł., "Helix-loop-helix peptide foldamers and their use in the construction of hydrolase mimetics." Bioorganic chemistry 81 (2018): 356-361, <a href="https://www.sciencedirect.com/science/article/pii/S0045206818303742" target="_blank">[Science Direct]</a></li>
	<li> <b>Węglarz-Tomczak, E.</b>, Talma, M., Giurg, M., Westerhoff, H. V., Janowski, R., & Mucha, A. (2018). Neutral metalloaminopeptidases APN and MetAP2 as newly discovered anticancer molecular targets of actinomycin D and its simple analogs. Oncotarget, 9(50), 29365., <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047675/" target="_blank">[NCBI]</a></li>
	<li> Szefczyk, M., <b>Węglarz‐Tomczak, E.</b>, Fortuna, P., Krzysztoń, A., Rudzińska‐Szostak, E., & Berlicki, Ł. (2017). Controlling the Helix Handedness of ααβ‐Peptide Foldamers through Sequence Shifting. Angewandte Chemie International Edition, 56(8), 2087-2091., <a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/anie.201610154" target="_blank">[Wiley Online]</a></li>
	<li> <b>Węglarz-Tomczak, E.</b>, Burda-Grabowska, M., Giurg, M., & Mucha, A. (2016). Identification of methionine aminopeptidase 2 as a molecular target of the organoselenium drug ebselen and its derivatives/analogues: Synthesis, inhibitory activity and molecular modeling study. Bioorganic & medicinal chemistry letters, 26(21), 5254-5259., <a href="https://www.sciencedirect.com/science/article/pii/S0960894X16309908" target="_blank">[Science Direct]</a></li>	
	<li> <b>Węglarz-Tomczak, E.</b>, Staszewska, K., Talma, M., & Mucha, A. (2016). Enantiomeric α, β-diaminoethylphosphonic acids as potent inhibitors of aminopeptidases—stereoselective synthesis and biological activity. Tetrahedron Letters, 57(43), 4812-4814., <a href="https://www.sciencedirect.com/science/article/pii/S0040403916312102" target="_blank">[Science Direct]</a></li>	
	<li> <b>Węglarz-Tomczak, E.</b>, Vassiliou, S., & Mucha, A. (2016). Discovery of potent and selective inhibitors of human aminopeptidases ERAP1 and ERAP2 by screening libraries of phosphorus-containing amino acid and dipeptide analogues. Bioorganic & medicinal chemistry letters, 26(16), 4122-4126., <a href="https://www.sciencedirect.com/science/article/pii/S0960894X16306734" target="_blank">[Science Direct]</a></li>
	<li> <b>Węglarz-Tomczak, E.</b>, Berlicki, Ł., Pawełczak, M., Nocek, B., Joachimiak, A., & Mucha, A. (2016). A structural insight into the P1 S1 binding mode of diaminoethylphosphonic and phosphinic acids, selective inhibitors of alanine aminopeptidases. European journal of medicinal chemistry, 117, 187-196., <a href="https://www.sciencedirect.com/science/article/pii/S0223523416303014" target="_blank">[Science Direct]</a></li>	
	<li> Vassiliou, S., <b>Węglarz-Tomczak, E.</b>, Berlicki, Ł., Pawełczak, M., Nocek, B., Mulligan, R., Joachimiak, A., & Mucha, A. (2014). Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases. Journal of medicinal chemistry, 57(19), 8140-8151., <a href="https://pubs.acs.org/doi/abs/10.1021/jm501071f" target="_blank">[ACS]</a></li>
	<li> <b>Węglarz-Tomczak, E.</b>, Poręba, M., Byzia, A., Berlicki, Ł., Nocek, B., Mulligan, R., Joachimiak, A., Drąg, M., & Mucha, A. (2013). An integrated approach to the ligand binding specificity of Neisseria meningitidis M1 alanine aminopeptidase by fluorogenic substrate profiling, inhibitory studies and molecular modeling. Biochimie, 95(2), 419-428., <a href="https://www.sciencedirect.com/science/article/pii/S0300908412004348?via%3Dihub" target="_blank">[Science Direct]</a></li>
	<li> <b>Węglarz-Tomczak, E.</b>, & Gorecki, L. (2012). Azo dyes—biological activity and synthetic strategy. Chemik, 66(12), 1298-1307., <a href="http://www.chemikinternational.com/pdf/2012/12_2012/chemik_12_12_003.pdf" target="_blank">[Chemik International]</a></li>
	</ol></p>
    </div>
  </div>

<!--    conference articles    --->
  <div class="item">
    <h3>Conferences (selected)</h3>
    <div class="description" align="justify">
      <p><ol>
	<li> Tomczak, J. M., <b>Weglarz-Tomczak, E.</b>, & Eiben, A. E. "Differential Evolution with Reversible Linear Transformations". GECCO 2020.</li>
	<li> Berlicki, L., Wojcik, P., Szefczyk, M., Drewniak, M., Ozga, K., <b>Weglarz-Tomczak, E.</b>, and others (2016, September). "Rational synthesis and evaluation of catalytically active peptide foldamers". In Journal of Peptide Science (Vol. 22, pp. S20-S20). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY.</li>
	<li> Talma, M., <b>Weglarz-Tomczak, E.</b>, Staszewska, K., & Mucha, A. (2016, September). "P1 and P1' modified phosphinic dipeptide analogue inhibitors of metalloaminopeptidases". In Journal of Peptide Science (Vol. 22, pp. S184-S184). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY.</li>
	<li> Mucha, A., Vassiliou, S., <b>Weglarz-Tomczak, E.</b>, Berlicki, L., Paweiczak, M., Nocek, B., and others (2013, May). "Inhibition of Neisseria meningitidis Alanine Aminopeptidase with Phosphinic Dipeptide Analogs". In Biopolymers (Vol. 100, No. 3, pp. 306-306). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL.</li>
	<li> <b>Węglarz-Tomczak, E.</b>, Vassiliou, S., Berlicki, Ł., Pawełczak, M., Nocek, B., Mulligan, R., and others. "Novel phosphorus-containing amino acid and dipeptide mimetics as highly potent inhibitors of neisseria meningitidis alanyl aminopeptidase". the 3rd Biotechnology World Congress, 2014. (<b>invited speech</b>)</li>
	<li> Gisztar, M.; Gorecki, Ł.; <b>Węglarz, E.</b>, Phosphorous-containing trasition state analogues as effective inhibitors of alanyl aminopeptidase. Papers of the Students of the Wrocław University of Technology, 8th Students 2012, 153.</li>
	<li> <b>Węglarz, E.</b>, Leucine aminopeptidases - significance and strategy for inhibition. On the borderline of chemistry and biology, Adam Mickiewicz University Press Poznan 2010, 81.</li>
	<li> <b>Węglarz, E.</b>; Mucha, A., The Organophosphorus Inhibitors of Leucine Aminopeptidase - Designing Strategy and Synthesis. Proceeding of III International Interdisciplinary Technical Conference of Young Scientists InterTech 2010, 503.</li>
	<li> <b>Węglarz, E.</b>; Mucha, A., Aminopeptidases as therapeutic targets. Papers of the Students of the Wrocław University of Technology, 8th Students 2010, 110.</li>
	<li> <b>Węglarz, E.</b>; Giurg, M., New methods of oxidativ cyclocondensation of ortho-aminophenols to 2-amino-3H-phenoxazin-3-ones and theirs N-2 derivatization. Papers of Faculty of Chemistry Wrocław University of Technology. Students Research Work 2009, 179.</li>
     </ol></p>
    </div>
  </div>

</div>

<div id="footer">
  <p>&copy; Ewelina Węglarz-Tomczak. All rights reserved.</p>
  <!-- Don't remove this link. Respect the designer. If you want to remove it, shoot me an email me@jonnotie.nl -->
</div>
</body>
</html>
